Research facility · founded 1983
Beckman Research Institute
- Citations, last 5 years
- 43.4k
- Works, last 5 years
- 2 597
- h-index
- 528
- Scientists listed
- 25
- Grants since 2016
- 719
Grants received
2021–2026 · research · R01
Identifying and engaging a universal adjuvant for breaking macrophage immune tolerance in cancer
Mingye Feng · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection
Javier Gordon Ogembo · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R00
Investigating the Role of Radiation-induced Cell Death in Innate Lymphoid Cell Activation within Unique Tumor Microenvironments
Heather Michelle Mcgee · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance
Jeremy Michael Stark · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
Vu Nguyen Ngo · Beckman Research Institute · funded by National Institutes of Health
2021–2023 · research · R21
Utilizing Hybrid Antigen-Presenting Neutrophils to Prime WT1-Specific Immune Responses as Therapy for Acute Leukemia
Edwin Manuel · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Validation of epigenomic biomarkers for thyroid cancer diagnostics
Maria Hahn · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
Javier Gordon Ogembo · Beckman Research Institute · funded by National Institutes of Health
2021–2025 · research · R01
The Role of Adipocyte Uridine Biosynthesis in Obesity and Diabetes Progression
Yingfeng Deng · Beckman Research Institute · funded by National Institutes of Health
2021–2023 · research · R56
Intestinal Regulation of Gut Microbiota and Metabolism
Wendong Huang · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R50
Improving Outcomes for Multiple Myeloma Patients through Novel Therapeutic Interventions
Enrico Caserta · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
Javier Gordon Ogembo · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Lihua Elizabeth Budde · Beckman Research Institute · funded by National Institutes of Health
2021–2027 · research · R01
Extreme weather, air pollution, and stroke among an aging female population
Sophia S Wang · Beckman Research Institute · funded by National Institutes of Health
2021–2027 · cooperative agreement · U01
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
Andrea Hope Bild · Beckman Research Institute · funded by National Institutes of Health
2021–2027 · cooperative agreement · U19
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
Behnam Badie · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Targeting tumor-associated macrophages for triple-negative breast cancer treatment
Mingye Feng · Beckman Research Institute · funded by National Institutes of Health
2021–2027 · research · R01
KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection
Javier Gordon Ogembo · Beckman Research Institute · funded by National Institutes of Health
2021–2027 · research · R01
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans
Steven Terry Rosen · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
BCL11B activation as an approach for enhancing the efficacy of immunotherapy
Chintan Parekh · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
Javier Gordon Ogembo · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · cooperative agreement · U19
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
Michael E. Berens · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · cooperative agreement · U19
Tasquinimod as an adjunct to immunotherapies administered peri-operatively
Jana Portnow · Beckman Research Institute · funded by National Institutes of Health
2021–2027 · cooperative agreement · U19
An engineered oncolytic herpes virus expressing a full-length α-CD47 mAb for the treatment of GBM
Behnam Badie · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · cooperative agreement · U19
Molecular Profiling and Bioinformatics
Michael E. Berens · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · cooperative agreement · U19
An engineered oncolytic herpes virus expressing a full-length α-CD47 mAb for the treatment of GBM
Jianhua Yu · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · cooperative agreement · U19
Analytical Immunopharmacology
Timothy W Synold · Beckman Research Institute · funded by National Institutes of Health
2021–2027 · cooperative agreement · U19
Tasquinimod as an adjunct to immunotherapies administered peri-operatively
Behnam Badie · Beckman Research Institute · funded by National Institutes of Health
2021–2027 · cooperative agreement · U19
Administrative Core
Jana Portnow · Beckman Research Institute · funded by National Institutes of Health
2021–2027 · cooperative agreement · U19
Molecular Profiling and Bioinformatics
Michael E. Berens · Beckman Research Institute · funded by National Institutes of Health
2020–2025 · research · R01
Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target?
Guido Marcucci · Beckman Research Institute · funded by National Institutes of Health
2020
Preclinical development of a first-in-class PCNA inhibitor for treating small cell lung cancer
Linda Malkas · Beckman Research Institute · funded by Office of the President, University of California
2020–2025 · research · R01
Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer
Virginia Chih-Yi Sun · Beckman Research Institute · funded by National Institutes of Health
2020–2025 · research · R01
Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers
Saro Armenian · Beckman Research Institute · funded by National Institutes of Health
2020–2025 · research · R01
Mammary Adipocyte Remodeling in Health and Disease
Qiong Annabel Wang · Beckman Research Institute · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Information flow and state transitions at the system and multi-dimensional scales in leukemia progression
Ya-Huei Kuo · Beckman Research Institute · funded by National Institutes of Health
2020–2025 · research · R01
Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation
Saro Armenian · Beckman Research Institute · funded by National Institutes of Health
2020–2025 · research · R25
Interdisciplinary Communication Training in Oncology
Betty R Ferrell · Beckman Research Institute · funded by National Institutes of Health
2020–2026 · research · R01
Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer
Terence Marques Williams · Beckman Research Institute · funded by National Institutes of Health
2020
A functional neutralization assay for discovery of SARS-CoV-2 protected people in California
Kevin Morris · Beckman Research Institute · funded by Office of the President, University of California